vs

Side-by-side financial comparison of Liberty Energy Inc. (LBRT) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Liberty Energy Inc.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 2.2%, a 2.2% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 4.5%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -6.2%).

Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

LBRT vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.5× larger
ONC
$1.5B
$1.0B
LBRT
Growing faster (revenue YoY)
ONC
ONC
+28.4% gap
ONC
32.8%
4.5%
LBRT
Higher net margin
ONC
ONC
2.2% more per $
ONC
4.4%
2.2%
LBRT
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
-6.2%
LBRT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LBRT
LBRT
ONC
ONC
Revenue
$1.0B
$1.5B
Net Profit
$22.6M
$66.5M
Gross Margin
90.5%
Operating Margin
2.2%
12.4%
Net Margin
2.2%
4.4%
Revenue YoY
4.5%
32.8%
Net Profit YoY
143.8%
EPS (diluted)
$0.14
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LBRT
LBRT
ONC
ONC
Q1 26
$1.0B
Q4 25
$1.0B
$1.5B
Q3 25
$947.4M
$1.4B
Q2 25
$1.0B
$1.3B
Q1 25
$977.5M
$1.1B
Q4 24
$943.6M
$1.1B
Q3 24
$1.1B
$1.0B
Q2 24
$1.2B
$929.2M
Net Profit
LBRT
LBRT
ONC
ONC
Q1 26
$22.6M
Q4 25
$13.7M
$66.5M
Q3 25
$43.1M
$124.8M
Q2 25
$71.0M
$94.3M
Q1 25
$20.1M
$1.3M
Q4 24
$51.9M
$-151.9M
Q3 24
$73.8M
$-121.3M
Q2 24
$108.4M
$-120.4M
Gross Margin
LBRT
LBRT
ONC
ONC
Q1 26
Q4 25
20.6%
90.5%
Q3 25
18.7%
86.1%
Q2 25
22.1%
87.5%
Q1 25
22.1%
85.2%
Q4 24
21.4%
85.8%
Q3 24
26.2%
83.0%
Q2 24
27.9%
85.1%
Operating Margin
LBRT
LBRT
ONC
ONC
Q1 26
2.2%
Q4 25
1.9%
12.4%
Q3 25
-0.3%
11.5%
Q2 25
3.6%
6.7%
Q1 25
1.9%
1.0%
Q4 24
2.6%
-7.0%
Q3 24
9.4%
-12.0%
Q2 24
12.2%
-11.5%
Net Margin
LBRT
LBRT
ONC
ONC
Q1 26
2.2%
Q4 25
1.3%
4.4%
Q3 25
4.5%
8.8%
Q2 25
6.8%
7.2%
Q1 25
2.1%
0.1%
Q4 24
5.5%
-13.5%
Q3 24
6.5%
-12.1%
Q2 24
9.3%
-13.0%
EPS (diluted)
LBRT
LBRT
ONC
ONC
Q1 26
$0.14
Q4 25
$0.08
$0.05
Q3 25
$0.26
$0.08
Q2 25
$0.43
$0.06
Q1 25
$0.12
$0.00
Q4 24
$0.31
$-0.10
Q3 24
$0.44
$-0.09
Q2 24
$0.64
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LBRT
LBRT
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$699.1M
$4.5B
Total DebtLower is stronger
$7.1M
$836.4M
Stockholders' EquityBook value
$1.9B
$4.4B
Total Assets
$4.4B
$8.2B
Debt / EquityLower = less leverage
0.00×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LBRT
LBRT
ONC
ONC
Q1 26
$699.1M
Q4 25
$27.6M
$4.5B
Q3 25
$13.5M
$4.0B
Q2 25
$19.6M
$2.8B
Q1 25
$24.1M
$2.5B
Q4 24
$20.0M
$2.6B
Q3 24
$23.0M
$2.7B
Q2 24
$30.0M
$2.6B
Total Debt
LBRT
LBRT
ONC
ONC
Q1 26
$7.1M
Q4 25
$246.6M
$836.4M
Q3 25
Q2 25
Q1 25
Q4 24
$190.5M
Q3 24
Q2 24
Stockholders' Equity
LBRT
LBRT
ONC
ONC
Q1 26
$1.9B
Q4 25
$2.1B
$4.4B
Q3 25
$2.1B
$4.1B
Q2 25
$2.0B
$3.8B
Q1 25
$2.0B
$3.5B
Q4 24
$2.0B
$3.3B
Q3 24
$2.0B
$3.4B
Q2 24
$1.9B
$3.4B
Total Assets
LBRT
LBRT
ONC
ONC
Q1 26
$4.4B
Q4 25
$3.6B
$8.2B
Q3 25
$3.5B
$7.6B
Q2 25
$3.4B
$6.3B
Q1 25
$3.4B
$5.8B
Q4 24
$3.3B
$5.9B
Q3 24
$3.3B
$5.8B
Q2 24
$3.2B
$5.7B
Debt / Equity
LBRT
LBRT
ONC
ONC
Q1 26
0.00×
Q4 25
0.12×
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LBRT
LBRT
ONC
ONC
Operating Cash FlowLast quarter
$417.3M
Free Cash FlowOCF − Capex
$379.8M
FCF MarginFCF / Revenue
25.4%
Capex IntensityCapex / Revenue
13.1%
2.5%
Cash ConversionOCF / Net Profit
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LBRT
LBRT
ONC
ONC
Q1 26
Q4 25
$195.4M
$417.3M
Q3 25
$51.5M
$402.6M
Q2 25
$170.6M
$263.6M
Q1 25
$192.1M
$44.1M
Q4 24
$177.3M
$75.2M
Q3 24
$244.5M
$188.4M
Q2 24
$248.2M
$-95.6M
Free Cash Flow
LBRT
LBRT
ONC
ONC
Q1 26
Q4 25
$-10.0M
$379.8M
Q3 25
$-67.2M
$354.5M
Q2 25
$33.1M
$219.8M
Q1 25
$58.2M
$-12.3M
Q4 24
$-26.2M
$-17.3M
Q3 24
$77.9M
$54.7M
Q2 24
$112.2M
$-205.5M
FCF Margin
LBRT
LBRT
ONC
ONC
Q1 26
Q4 25
-1.0%
25.4%
Q3 25
-7.1%
25.1%
Q2 25
3.2%
16.7%
Q1 25
6.0%
-1.1%
Q4 24
-2.8%
-1.5%
Q3 24
6.8%
5.5%
Q2 24
9.7%
-22.1%
Capex Intensity
LBRT
LBRT
ONC
ONC
Q1 26
13.1%
Q4 25
19.8%
2.5%
Q3 25
12.5%
3.4%
Q2 25
13.2%
3.3%
Q1 25
13.7%
5.0%
Q4 24
21.6%
8.2%
Q3 24
14.6%
13.3%
Q2 24
11.7%
11.8%
Cash Conversion
LBRT
LBRT
ONC
ONC
Q1 26
Q4 25
14.28×
6.28×
Q3 25
1.20×
3.22×
Q2 25
2.40×
2.79×
Q1 25
9.55×
34.71×
Q4 24
3.42×
Q3 24
3.31×
Q2 24
2.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons